Xtant Medical Holdings (AMEX: XTNT)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | ||||||
REV | 14.020M | 12.959M | -1.061M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Xtant Medical Holdings (AMEX: XTNT) through any online brokerage.
There are no as such competitors for Xtant Medical Holdings.
The latest price target for Xtant Medical Holdings (AMEX: XTNT) was reported by Maxim Group on Friday, May 17, 2019. The analyst firm set a price target for 0.00 expecting XTNT to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Xtant Medical Holdings (AMEX: XTNT) is $0.49 last updated July 1, 2022, 7:41 PM UTC.
There are no upcoming dividends for Xtant Medical Holdings.
Xtant Medical Holdings’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Xtant Medical Holdings.
Xtant Medical Holdings is in the Healthcare sector and Medical Devices industry. They are listed on the AMEX.